Search
Descriptor English: Methiothepin
Descriptor Spanish: Metiotepina
Descriptor metiotepina
Entry term(s) metiltepina
Scope note: Antagonista del receptor de serotonina en el SISTEMA NERVIOSO CENTRAL utilizado como antipsicótico.
Descriptor Portuguese: Metiotepina
Descriptor French: Métitépine
Entry term(s): Maleate, Methiothepin
Methiothepin Maleate
Methiothepine
Metitepine
Tree number(s): D02.886.680.350.520
D03.633.300.311.520
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008719
Scope note: A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Serotonin Antagonists
Antipsychotic Agents
Registry Number: 55D94103HL
CAS Type 1 Name: Piperazine, 1-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-
Previous Indexing: Dibenzothiepins (1968-1975)
Piperazines (1973-1975)
Sulfides (1973-1975)
Public MeSH Note: 91; was see under DIBENZOTHIEPINS 1976-90
History Note: 91(76); was see under DIBENZOTHIEPINS 1976-90
DeCS ID: 8897
Unique ID: D008719
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1991/01/01
Date of Entry: 1975/07/23
Revision Date: 2016/05/31
Methiothepin - Preferred
Concept UI M0013581
Scope note A serotonin receptor antagonist in the CENTRAL NERVOUS SYSTEM used as an antipsychotic.
Preferred term Methiothepin
Entry term(s) Methiothepine
Metitepine
Methiothepin Maleate - Narrower
Concept UI M0013582
Preferred term Methiothepin Maleate
Entry term(s) Maleate, Methiothepin



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey